What is Royal Bank of Canada's earnings per share (EPS)?

Royal Bank of Canada (RY) reported diluted earnings per share of $10.04 for fiscal year 2025. This represents a 24.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Royal Bank of Canada (RY) Financials

RY NYSE

Trailing 12 months to January 31, 2026

Revenue $49.1B +13.6% YoY

Net Income $15.2B +20.0% YoY

EPS (Diluted) $10.55 +20.4% YoY

Operating Cash Flow $45.5B +15.6% YoY

Market Cap $280.3B as of Oct 26, 2026

Price / Sales 5.7x on $49.1B revenue, trailing 12 months to January 31, 2026

Price / Earnings 18.4x on $15.2B net income, trailing 12 months to January 31, 2026

Price / Book 2.7x on $103.1B equity, Q1 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (40-F/6-K) Latest period Q1 FY2026, ended Jan 31, 2026 Reported Feb 26, 2026 Currency USD FYE October

Newest figures come from the 6-K for Q1 FY2026, filed Feb 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RY SEC filings page.

Royal Bank of Canada (RY) reported $49.1B in revenue over the twelve months to Jan 31, 2026, up 13.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 9 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Health Score (4 of 6 dimensions) 51/100

Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Royal Bank of Canada's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings

Royal Bank of Canada earned a return on assets of 0.9% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 0.8% the prior year. Earnings ranks banks on that return over three years, and Royal Bank of Canada scores 45/100 among other banks.

Growth

Royal Bank of Canada reported revenue of $47.5B in fiscal year 2025, against $41.1B in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Royal Bank of Canada scores 68/100 among other banks.

Capital

Royal Bank of Canada funded 6.0% of its assets with shareholders' equity at the end of fiscal year 2025, holding $99.3B of equity against $1.7T of assets. Capital ranks banks on that cushion, and Royal Bank of Canada scores 6/100 among other banks.

Efficiency

n/a

Not available for Royal Bank of Canada, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Credit Quality

n/a

Not available for Royal Bank of Canada, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.

Stability

Royal Bank of Canada reported net income of $14.5B in fiscal year 2025, against $11.6B in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Royal Bank of Canada scores 85/100 among other banks.

Piotroski F-Score Partial

6/6

Royal Bank of Canada passes 6 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$13.2B

YoY+14.4%

QoQ+7.9%

5Y CAGR+5.5%

Royal Bank of Canada generated $13.2B in revenue in Q1 2026. This represents an increase of 14.4% from the same quarter a year earlier. Against the prior quarter it is up 7.9%.

Net Income

$4.3B

YoY+20.3%

QoQ+10.0%

5Y CAGR+7.2%

Royal Bank of Canada reported $4.3B in net income in Q1 2026. This represents an increase of 20.3% from the same quarter a year earlier. Against the prior quarter it is up 10.0%.

EPS (Diluted)

$2.97

YoY+21.4%

QoQ+10.8%

5Y CAGR+7.4%

Royal Bank of Canada earned $2.97 per diluted share (EPS) in Q1 2026. This represents an increase of 21.4% from the same quarter a year earlier. Against the prior quarter it is up 10.8%.

EBITDA

Not reported for Q1 2026.

Cash & Balance Sheet

Cash & Debt

$34.1B

YoY-30.8%

QoQ+29.0%

5Y CAGR-21.9%

Royal Bank of Canada held $34.1B in cash as of Q1 2026; no long-term debt figure is on record for that period.

Shares Outstanding

Diluted avg 1.40B

Royal Bank of Canada had a weighted average of 1.40B diluted shares in Q1 2026; the shares outstanding count is not reported for that period.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Net Margin

32.2%

YoY+1.6pp

QoQ+0.6pp

5Y change+2.5pp

Royal Bank of Canada's net profit margin was 32.2% in Q1 2026, showing the share of revenue converted to profit. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Return on Equity

4.1%

YoY+0.3pp

QoQ+0.2pp

5Y change-0.1pp

Royal Bank of Canada's quarterly ROE was 4.1% in Q1 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.

Gross Margin

Not reported for Q1 2026.

Operating Margin

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

RY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RY quarterly income statement

Metric	TTM	FY2540-F	FY2440-F	FY2340-F	FY2240-F	FY2140-F	FY2040-F	FY1940-F	FY1840-F	FY1740-F
Revenue	$49.1B	$47.5B+15.6%	$41.1B+10.9%	$37.1B+3.3%	$35.9B-10.4%	$40.1B+13.3%	$35.4B+1.1%	$35.0B+7.9%	$32.4B+2.8%	$31.5B
Interest Expense	$50.6B	$50.6B-8.5%	$55.2B+23.9%	$44.6B+236.7%	$13.2B+101.5%	$6.6B-37.7%	$10.5B-35.8%	$16.4B+43.1%	$11.5B+51.6%	$7.6B
Income Tax	$4.1B	$3.8B+45.1%	$2.6B+1.0%	$2.6B-18.4%	$3.2B-14.6%	$3.7B+66.9%	$2.2B-4.4%	$2.3B-8.7%	$2.5B+2.1%	$2.5B
Net Income	$15.2B	$14.5B+24.8%	$11.6B+10.6%	$10.5B-9.1%	$11.6B-10.5%	$12.9B+50.9%	$8.6B-12.4%	$9.8B+3.6%	$9.4B+6.6%	$8.9B
EPS (Basic)	N/A	$10.06+24.5%	$8.09+8.6%	$7.44-8.4%	$8.12-9.1%	$8.94+52.0%	$5.88-12.0%	$6.68	$6.39+8.6%	$5.89
EPS (Diluted)	$10.55	$10.04+24.4%	$8.07+8.5%	$7.44-8.3%	$8.11-9.1%	$8.92+52.1%	$5.87-11.9%	$6.66	$6.37+8.6%	$5.86
Diluted Shares (Avg)	N/A	1.41B-0.2%	1.41B+1.5%	1.39B-1.0%	1.41B-1.5%	1.43B-0.1%	1.43B-0.8%	1.44B	1M-1.6%	1M

Metric	Q1'266-K	Q4'2540-F	Q3'256-K	Q2'256-K	Q1'256-K	Q4'2440-F	Q3'246-K	Q2'246-K
Revenue	$13.2B+14.4%	$12.3B+13.6%	$12.3B+15.8%	$11.4B+10.3%	$11.6B+14.9%	$10.8B+18.3%	$10.6B+7.5%	$10.3B+12.1%
Interest Expense	$12.9B+1.0%	$12.6B-6.8%	$12.8B-10.4%	$12.3B-12.0%	$12.8B-11.1%	$13.5B+4.4%	$14.3B+13.8%	$13.9B+32.6%
Income Tax	$1.2B+32.9%	$995.0M+39.7%	$1.1B+63.9%	$817.0M+15.1%	$900.5M+57.3%	$712.4Mn/m	$642.5M+14.9%	$709.9M+25.8%
Net Income	$4.3B+20.3%	$3.9B+28.1%	$3.9B+20.4%	$3.2B+10.6%	$3.5B+32.6%	$3.0B+6.7%	$3.2B+10.8%	$2.9B+5.8%
EPS (Basic)	$2.97+21.4%	$2.69+28.5%	$2.72+21.3%	$2.19+9.7%	$2.45+31.1%	$2.09+0.2%	$2.24+7.9%	$2.00+4.3%
EPS (Diluted)	$2.97+21.4%	$2.68+28.6%	$2.71+21.0%	$2.19+9.7%	$2.45+31.1%	$2.09-0.1%	$2.24+7.9%	$1.99+3.9%
Diluted Shares (Avg)	1.40B-1.0%	N/A	1.41B-0.5%	1.41B0.0%	1.42B+0.6%	N/A	1.42B+1.5%	1.41B+1.7%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

RY Balance Sheet

RY quarterly balance sheet

Metric	FY2540-F	FY2440-F	FY2340-F	FY2240-F	FY2140-F	FY2040-F	FY1940-F	FY1840-F	FY1740-F
Total Assets	$1.7T+6.5%	$1.6T+7.8%	$1.4T+2.9%	$1.4T+2.1%	$1.4T+13.0%	$1.2T+12.1%	$1.1T+6.9%	$1.0T+8.1%	$940.6B
Cash & Equivalents	$26.4B-35.1%	$40.7B-8.9%	$44.7B-15.9%	$53.1B-42.2%	$91.8B+3.0%	$89.2B+345.5%	$20.0B-13.0%	$23.0B+4.4%	$22.0B
Goodwill	$13.9B+0.1%	$13.8B+52.5%	$9.1B+0.8%	$9.0B+2.8%	$8.8B+3.3%	$8.5B-0.8%	$8.5B+0.8%	$8.5B-0.4%	$8.5B
Total Liabilities	$1.6T+6.4%	$1.5T+7.6%	$1.4T+2.8%	$1.3T+2.3%	$1.3T+12.4%	$1.2T+12.7%	$1.0T+7.1%	$955.7B+8.2%	$882.9B
Total Equity	$99.3B+8.9%	$91.2B+10.0%	$82.9B+4.6%	$79.2B-0.4%	$79.6B+22.4%	$65.0B+2.3%	$63.5B+4.5%	$60.8B+6.2%	$57.3B
Retained Earnings	$69.2B+8.8%	$63.6B+8.0%	$58.9B+2.9%	$57.2B-1.2%	$57.9B+29.1%	$44.9B+5.3%	$42.6B+9.4%	$38.9B+10.7%	$35.2B

Metric	Q1'266-K	Q4'2540-F	Q3'256-K	Q2'256-K	Q1'256-K	Q4'2440-F	Q3'246-K	Q2'246-K
Total Assets	$1.7T+14.0%	$1.7T+6.5%	$1.6T+7.0%	$1.6T+9.9%	$1.5T+2.7%	$1.6T+7.8%	$1.5T+1.1%	$1.5T+3.2%
Cash & Equivalents	$34.1B-30.8%	$26.4B-35.1%	$25.2B-36.9%	$35.2B-21.1%	$49.2B-11.4%	$40.7B-8.9%	$40.0B-34.5%	$44.6B-39.0%
Goodwill	$14.2B+4.9%	$13.9B+0.1%	$14.0B+0.7%	$14.0B+0.9%	$13.5B+45.8%	$13.8B+52.5%	$13.9B+48.2%	$13.8B+50.5%
Total Liabilities	$1.6T+14.2%	$1.6T+6.4%	$1.5T+6.9%	$1.5T+10.0%	$1.4T+2.5%	$1.5T+7.6%	$1.4T+0.8%	$1.4T+2.9%
Total Equity	$103.1B+12.0%	$99.3B+8.9%	$97.9B+8.7%	$95.9B+8.5%	$92.1B+5.9%	$91.2B+10.0%	$90.1B+5.6%	$88.4B+7.7%
Retained Earnings	$73.2B+16.7%	$69.2B+8.8%	$68.6B+10.0%	$67.3B+10.5%	$62.8B+2.4%	$63.6B+8.0%	$62.3B0.0%	$60.9B+2.8%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

RY Cash Flow Statement

RY quarterly cash flow statement

Metric	TTM	FY2540-F	FY2440-F	FY2340-F	FY2240-F	FY2140-F	FY2040-F	FY1940-F	FY1840-F	FY1740-F
Operating Cash Flow	$45.5B	$39.4B+137.4%	$16.6B-11.7%	$18.8B+16.8%	$16.1B-67.3%	$49.2B-52.7%	$104.1B+859.4%	$10.9B-18.5%	$13.3B-54.5%	$29.3B
Investing Cash Flow	-$57.8B	-$48.9Bn/m	-$15.0Bn/m	-$20.4Bn/m	-$41.8Bn/m	-$46.3Bn/m	-$29.7Bn/m	-$8.5Bn/m	-$6.1Bn/m	-$12.0B
Financing Cash Flow	-$4.9B	-$4.8Bn/m	-$5.8Bn/m	-$7.1Bn/m	-$1.6Bn/m	-$4.8Bn/m	-$5.8Bn/m	-$5.7Bn/m	-$5.9Bn/m	-$6.7B
Dividends Paid	N/A	N/A	N/A	N/A	$5.1B-1.5%	$5.2B+9.0%	$4.8B+3.6%	$4.6B+6.7%	$4.3B+4.3%	$4.1B
Share Buybacks	N/A	N/A	N/A	N/A	$4.2B+9.3%	$3.8B+5.1%	$3.6B-14.0%	$4.2B-2.9%	$4.4B+25.2%	$3.5B

Metric	Q1'266-K	Q4'2540-F	Q3'256-K	Q2'256-K	Q1'256-K	Q4'2440-F	Q3'246-K	Q2'246-K
Operating Cash Flow	$28.0B+29.7%	-$10.6B-185.7%	$20.9B+24.5%	$7.1Bn/m	$21.5Bn/m	$12.3Bn/m	$16.8B+144.9%	-$11.3B-249.2%
Investing Cash Flow	-$19.7Bn/m	$12.4Bn/m	-$27.4Bn/m	-$23.1B-656.1%	-$11.1B-205.6%	-$9.3Bn/m	-$20.1Bn/m	$4.2B+2.3%
Financing Cash Flow	-$944.9Mn/m	-$471.8Mn/m	-$2.8Bn/m	-$662.7Mn/m	-$851.4M-3355.6%	-$2.1Bn/m	-$2.1Bn/m	-$1.7Bn/m

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

RY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RY quarterly financial ratios

Metric	FY2540-F	FY2440-F	FY2340-F	FY2240-F	FY2140-F	FY2040-F	FY1940-F	FY1840-F	FY1740-F
Net Margin	30.6%+2.3pp	28.3%-0.1pp	28.4%-3.9pp	32.2%0.0pp	32.3%+8.0pp	24.2%-3.7pp	28.0%-1.2pp	29.1%+1.0pp	28.1%
Return on Equity	14.6%+1.9pp	12.8%+0.1pp	12.7%-1.9pp	14.6%-1.6pp	16.3%+3.1pp	13.2%-2.2pp	15.4%-0.1pp	15.5%+0.1pp	15.5%
Return on Assets	0.9%+0.1pp	0.8%0.0pp	0.7%-0.1pp	0.8%-0.1pp	0.9%+0.2pp	0.7%-0.2pp	0.9%0.0pp	0.9%0.0pp	0.9%
Liabilities-to-Equity	15.72-0.4x	16.09-0.4x	16.44-0.3x	16.74+0.4x	16.29-1.5x	17.74+1.6x	16.11+0.4x	15.71+0.3x	15.42
Asset Turnover	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.030.0x	0.03

Metric	Q1'266-K	Q4'2540-F	Q3'256-K	Q2'256-K	Q1'256-K	Q4'2440-F	Q3'246-K	Q2'246-K
Net Margin	32.2%+1.6pp	31.6%+3.6pp	31.9%+1.2pp	28.0%+0.1pp	30.6%+4.1pp	28.0%-3.1pp	30.6%+0.9pp	27.9%-1.7pp
Return on Equity	4.1%+0.3pp	3.9%+0.6pp	4.0%+0.4pp	3.3%+0.1pp	3.9%+0.8pp	3.3%-0.1pp	3.6%+0.2pp	3.3%-0.1pp
Return on Assets	0.3%0.0pp	0.2%0.0pp	0.2%0.0pp	0.2%0.0pp	0.2%+0.1pp	0.2%0.0pp	0.2%0.0pp	0.2%0.0pp
Liabilities-to-Equity	15.75+0.3x	15.72-0.4x	15.43-0.3x	15.93+0.2x	15.45-0.5x	16.09-0.4x	15.69-0.7x	15.72-0.7x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, Debt-to-Equity, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Royal Bank of Canada RY	FY2025	$47.5B	$14.5B	30.6%	$280.3B	51/100
Wells Fargo & Co. WFC	FY2025	$83.7B	$21.3B	25.5%	$248.1B	42/100
HSBC Holdings plc HSBC	FY2025	$68.3B	$23.1B	33.9%	$311.9B	31/100
Bank of America Corporation BAC	FY2025	$113.1B	$30.5B	27.0%	$349.7B	51/100
JPMorgan Chase & Co. JPM	FY2025	$182.4B	$57.0B	31.3%	$887.1B	52/100
Citigroup Inc. C	FY2025	$85.2B	$14.3B	16.8%	$200.3B	31/100

Where Royal Bank of Canada Ranks

Frequently Asked Questions

What is Royal Bank of Canada's annual revenue?

Royal Bank of Canada (RY) reported $47.5B in total revenue for fiscal year 2025. This represents a 15.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Royal Bank of Canada's revenue growing?

Royal Bank of Canada (RY) revenue grew by 15.6% year-over-year, from $41.1B to $47.5B in fiscal year 2025.

Is Royal Bank of Canada profitable?

Yes, Royal Bank of Canada (RY) reported a net income of $15.2B over the trailing 12 months to January 31, 2026. In fiscal year 2025 it reported a net income of $14.5B, with a net profit margin of 30.6%.

What is Royal Bank of Canada's net profit margin?

Royal Bank of Canada (RY) had a net profit margin of 30.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Royal Bank of Canada's return on equity (ROE)?

Royal Bank of Canada (RY) has a return on equity of 14.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Royal Bank of Canada's operating cash flow?

Royal Bank of Canada (RY) generated $39.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Royal Bank of Canada's total assets?

Royal Bank of Canada (RY) had $1.7T in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Royal Bank of Canada have outstanding?

Royal Bank of Canada (RY) had 1.40B shares outstanding as of fiscal year 2025.

What is Royal Bank of Canada's liabilities-to-equity ratio?

Royal Bank of Canada (RY) had a liabilities-to-equity ratio of 15.72 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

What is Royal Bank of Canada's return on assets (ROA)?

Royal Bank of Canada (RY) had a return on assets of 0.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Royal Bank of Canada's P/E ratio?

Royal Bank of Canada (RY) trades at 18.4x earnings, its market capitalization divided by $15.2B net income, trailing 12 months to January 31, 2026. The market capitalization is $280.3B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Royal Bank of Canada's price-to-sales ratio?

Royal Bank of Canada (RY) trades at 5.7x sales, its market capitalization divided by $49.1B revenue, trailing 12 months to January 31, 2026. The market capitalization is $280.3B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Royal Bank of Canada's Piotroski F-Score?

Royal Bank of Canada (RY) has a Piotroski F-Score of 6 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

How financially healthy is Royal Bank of Canada?

Royal Bank of Canada (RY) scores 51 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is the average of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Royal Bank of Canada it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.